Literature DB >> 7296788

Digitalis-associated cardiac mortality after myocardial infarction.

A J Moss, H T Davis, D L Conard, J J DeCamilla, C L Odoroff.   

Abstract

The effect of digitalis therapy on 4-month posthospital cardiac mortality was investigated in 812 patients who survived the hospital phase of acute myocardial infraction. A stepwise multiple logistic regression analysis was used to identify variables associated with increased mortality and to adjust for differences in confounding variables between digitalis and nondigitalis patients. The major 4-month mortality (10 of 26 patients [38.5%]) occurred in digitalis-treated patients with congestive heart failure in the coronary care unit and complex ventricular premature depolarizations (VPDs) on the predischarge Holter recording. Logistic analyses that controlled for confounding variables indicated that digitalis use contributed to the increased mortality rate in this high-risk subset. The predicted mortality difference due to digitalis in patients with congestive heart failure and complex VPDs, adjusted for relevant nondigitalis risk factor variables, was 30% (90% confidence interval 18-42%). This retrospective study suggests that digitalis use increases the early posthospital mortality of myocardial infarction patients with combined electrical and mechanical dysfunction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296788     DOI: 10.1161/01.cir.64.6.1150

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  Digoxin after myocardial infarction. Does it have a role?

Authors:  G D Johnston
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.

Authors:  R Padrini; M Panfili; G Magnolfi; D Piovan; D Casarotto; M Ferrari
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  When, and when not, to use digoxin in the elderly.

Authors:  A T Gosselink; D J van Veldhuisen; H J Crijns
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 5.  Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

Review 6.  Recent developments in the treatment of congestive heart failure.

Authors:  W B Hood
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

7.  Deleterious effects of digitalis on reperfusion-induced arrhythmias and myocardial injury in ischemic rat hearts: possible involvements of myocardial Na+ and Ca2+ imbalance.

Authors:  M Tani; J R Neely
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

Review 8.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 9.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

Review 10.  Digitalis for treatment of heart failure in patients in sinus rhythm.

Authors:  William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; John J V McMurray
Journal:  Cochrane Database Syst Rev       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.